Overview

• Shares began trading under the tickers ETHZ and ETHZW on Aug. 18 following the formal name change from 180 Life Sciences.
• The company disclosed a holding of 94,675 ETH acquired at an average price of $3,902, valued at about $419 million at recent prices.
• The pivot was financed by roughly $565 million from PIPE and convertible note deals that drew more than 60 institutional and crypto-native investors, including Polychain, Founders Fund, Electric Capital, GSR and Borderless Capital.
• ETHZilla appointed Electric Capital as external asset manager to run strategies such as staking, DeFi lending and liquidity provision intended to outperform basic staking yields.
• ETHZ shares fell more than 4% in after-hours trading as Ethereum prices slipped, after closing higher during the regular session.